DEPARTAMENTO DE SALUD GOBIERNO VASCO

Their core work

The Basque Country Department of Health is the regional public health authority for Spain's Basque region, responsible for healthcare policy, regulation, and service delivery. Within H2020, they contribute real-world health system data — hospital discharge records, prescription databases, and population health registries — to European research consortia studying congenital anomalies, medical device safety, and precision medicine. Their role is that of a health system partner providing clinical infrastructure, regulatory perspective, and patient data access that academic-only consortia cannot offer. They bridge the gap between health technology developers and the realities of clinical deployment within a regional health system.

What they specialise in

How they've shifted over time

Their early H2020 involvement (2017) centered on epidemiological surveillance — tracking congenital anomalies, child mortality and morbidity through linked health records via EUROlinkCAT. From 2019 onward, they shifted toward health technology governance: medical device testing (TBMED, SAFE-N-MEDTECH) and precision medicine integration (ExACT). This reflects a move from passive data provision toward active engagement in how new health technologies are evaluated, regulated, and adopted within public health systems.

They are moving toward becoming a regulatory and clinical validation partner for health technology developers who need real-world evidence from a functioning public health system.

How they like to work

They exclusively participate as a third party or junior partner — never as coordinator. With 93 unique partners across 24 countries from just 4 projects, they join large, well-established European consortia rather than leading small targeted collaborations. This signals an organization that provides specific assets (data, clinical infrastructure, regulatory insight) to major research networks rather than driving research agendas. Expect them to be a reliable contributor within a defined scope, not a project initiator.

Despite only 4 projects, they have touched 93 unique partners across 24 countries — a consequence of joining very large European consortia. Their network is broad but indirect, built through participation in major multi-partner initiatives rather than through bilateral relationships.

What sets them apart

As a regional government health authority, they offer something universities and companies cannot: direct access to population-level health data, hospital records, and the regulatory environment of a real healthcare system. For medical device developers or precision health researchers, partnering with an actual health department means access to real deployment conditions, patient pathways, and policy-level decision-making. This makes them particularly valuable for projects that need clinical validation or health technology assessment within a public system context.

Highlights from their portfolio

• SAFE-N-MEDTECH
  Their only project with direct EC funding (EUR 267,322), focused on safety testing for nanotechnology-enabled medical devices across their full lifecycle.
• EUROlinkCAT
  A major European birth defect cohort study (2017-2022) linking congenital anomaly registries with health outcome data across multiple countries.
• ExACT
  A staff exchange network (MSCA-RISE) connecting health system practitioners to integrate precision medicine into real healthcare delivery — signals their interest in workforce capacity building.